27 Oct 2025 | 5 Mins Read
Dr Reddy's Q2 results spark buying, selling, and holding options
Flipitmoney
Dr Reddy's Laboratories reported a 7.25% year-on-year rise in consolidated net profit to Rs 1,347 crore for the quarter ended September 30. Revenue from operations climbed 10% to Rs 8,828 crore, while operating profit declined 3.23% to Rs 2,010 crore. Multiple brokerages maintained a bullish stance, trimming estimates due to near-term earnings headwinds but highlighting potential growth triggers.